# Biomatter raises $18M to expand AI enzyme design and testing

_Published Thursday, November 12, 2026 at 6:20 AM EST · Capital, AI · Latest · Tier 2 — Notable_

![Biomatter raises $18M to expand AI enzyme design and testing — Primary](https://media.thenextweb.com/2026/11/biomatter-team-2026-vilnius-group-photo.jpg)

Lithuania's Biomatter has raised $18M in a Series A round led by Astanor to expand its AI enzyme design platform, The Next Web reported. Existing investors UVC Partners, Inventure and Metaplanet also participated. The company did not disclose a valuation.

Biomatter combines computational models with laboratory testing to design enzymes, proteins that speed up chemical reactions, for specific industrial uses. It plans to use the funding to open a 2,000 m² design and testing facility in Vilnius in 2027 and expand its commercial team and US presence. The company says the facility should shorten design cycles from weeks to days.

## Sources

- [The Next Web](https://thenextweb.com/news/biomatter-18m-series-a-ai-enzyme-design)

---
Canonical: https://techandbusiness.org/newswire/CkJWhMl-zsqjyt7k5tN_iC
Published: 2026-11-12T11:20:48.074Z
Story chronology: 2026-11-12T09:45:09.000Z
Retrieved: 2026-11-12T13:52:51.673Z
Publisher: Tech & Business (techandbusiness.org)